These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15291543)

  • 21. Expression and purification of a recombinant peptide from the Alzheimer's beta-amyloid protein for solid-state NMR.
    Sharpe S; Yau WM; Tycko R
    Protein Expr Purif; 2005 Jul; 42(1):200-10. PubMed ID: 15939307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for C-terminal sequence analysis in the proteomic era (proteins cleaved with cyanogen bromide).
    Samyn B; Sergeant K; Van Beeumen J
    Nat Protoc; 2006; 1(1):318-23. PubMed ID: 17406252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein ligation: an enabling technology for the biophysical analysis of proteins.
    Muralidharan V; Muir TW
    Nat Methods; 2006 Jun; 3(6):429-38. PubMed ID: 16721376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of cyanogen bromide fragments from beta-2-glycoprotein I by high-performance liquid chromatography.
    Lozier J; Takahashi N; Putnam FW
    J Chromatogr; 1983 Aug; 266():545-54. PubMed ID: 6630361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of poly-histidine fusion tags from recombinant proteins purified by expanded bed adsorption.
    Abdullah N; Chase HA
    Biotechnol Bioeng; 2005 Nov; 92(4):501-13. PubMed ID: 16080185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of unnatural amino acids into proteins using expressed protein ligation.
    Ayers B; Blaschke UK; Camarero JA; Cotton GJ; Holford M; Muir TW
    Biopolymers; 1999; 51(5):343-54. PubMed ID: 10685045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semisynthesis of proteins using split inteins.
    Ludwig C; Schwarzer D; Zettler J; Garbe D; Janning P; Czeslik C; Mootz HD
    Methods Enzymol; 2009; 462():77-96. PubMed ID: 19632470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bond.
    Way JC; Lauder S; Brunkhorst B; Kong SM; Qi A; Webster G; Campbell I; McKenzie S; Lan Y; Marelli B; Nguyen LA; Degon S; Lo KM; Gillies SD
    Protein Eng Des Sel; 2005 Mar; 18(3):111-8. PubMed ID: 15820978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An improved strategy for high-level production of human vasostatin120-180.
    Sun QM; Chen LL; Cao L; Fang L; Chen C; Hua ZC
    Biotechnol Prog; 2005; 21(4):1048-52. PubMed ID: 16080682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the stability of nonglycosylated wild-type erythropoietin protein via reiterative alanine ligations.
    Brailsford JA; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7196-201. PubMed ID: 22499784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid purification of the potato ADP-glucose pyrophosphorylase by polyhistidine-mediated chromatography.
    Hwang SK; Salamone PR; Kavakli H; Slattery CJ; Okita TW
    Protein Expr Purif; 2004 Nov; 38(1):99-107. PubMed ID: 15477087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional structure of the somatomedin B domain of vitronectin.
    Zhou A
    Protein Sci; 2007 Jul; 16(7):1502-8. PubMed ID: 17567740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of N-terminal Cys-protein fragments using an intein refolding strategy.
    Hackenberger CP; Chen MM; Imperiali B
    Bioorg Med Chem; 2006 Jul; 14(14):5043-8. PubMed ID: 16554163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid synthesis of DNA-cysteine conjugates for expressed protein ligation.
    Lovrinovic M; Niemeyer CM
    Biochem Biophys Res Commun; 2005 Sep; 335(3):943-8. PubMed ID: 16102730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of cyanogen bromide cleavage yields for methionyl-serine and methionyl-threonine peptide bonds.
    Kaiser R; Metzka L
    Anal Biochem; 1999 Jan; 266(1):1-8. PubMed ID: 9887207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-dimensional gel electrophoretic analysis of cyanogen bromide fragments containing subdomain VIB of protein kinases using a Multi-PK antibody.
    Sugiyama Y; Shimomura S; Sueyoshi N; Kameshita I
    Anal Biochem; 2008 Feb; 373(1):173-5. PubMed ID: 17963683
    [No Abstract]   [Full Text] [Related]  

  • 38. Overexpression, purification, and pharmacological activity of a biosynthetically derived conopeptide.
    Kumar GS; Ramasamy P; Sikdar SK; Sarma SP
    Biochem Biophys Res Commun; 2005 Sep; 335(3):965-72. PubMed ID: 16115470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intein-containing chimeric protein construction and evaluation of its cleavage conditions].
    Starokadomskiĭ PL; Dubeĭ IIa; Okunev OV; Irodov DM
    Tsitol Genet; 2007; 41(2):3-11. PubMed ID: 17494337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coupling antibody to cyanogen bromide-activated sepharose.
    Kavran JM; Leahy DJ
    Methods Enzymol; 2014; 541():27-34. PubMed ID: 24674060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.